Status:
Concluded with an LOI
Manufacturer:
AbbVie Corporation
Indication:
Hidradenitis Suppurativa
Last updated October 23, 2017
Invokamet (canagliflozin/metformin hydrochloride)
Status:
Concluded without agreement
Manufacturer:
Janssen Inc.
Indication:
Diabetes Mellitus, Type 2
Last updated October 20, 2017
Status:
Concluded with an LOI
Manufacturer:
Sandoz Canada Inc.
Indication:
Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis
Last updated October 17, 2017
Status:
Concluded with an LOI
Manufacturer:
Amgen Canada Inc.
Indication:
Osteoporosis in Men
Last updated October 17, 2017
Status:
Concluded without agreement
Manufacturer:
Mylan Pharmaceuticals LLC
Indication:
Alcohol Abstinence
Last updated September 29, 2017
Truvada (emtricitabine/tenofovir disoproxil fumarate)
Status:
Negotiations were not pursued
Manufacturer:
Gilead Sciences Canada Inc.
Indication:
HIV-1 infection, pre-exposure prophylaxis
Last updated September 8, 2017
Status:
Concluded without agreement
Manufacturer:
Celgene Inc.
Indication:
Psoriatic Arthritis
Last updated September 8, 2017
Status:
Concluded without agreement
Manufacturer:
Celgene Inc.
Indication:
Psoriasis, moderate to severe plaque
Last updated September 8, 2017
Status:
Concluded with an LOI
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Indication:
Neuroendocrine tumours of Gastrointestinal or Lung origin
Last updated September 1, 2017
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
Platinum-Resistant Ovarian Cancer
Last updated August 21, 2017